DLB proposes sale of restricted common shares

DLB submitted a Form 144 notice listing proposed sales of Common Stock that are restricted or performance-based.

Rhea-AI Filing Summary

DLB submitted a Form 144 notice listing proposed sales of Common Stock that are restricted or performance-based. The filing lists multiple lots with sale dates of 12/15/2025 and 12/16/2025, including examples of 2,109 and 1,928 shares.

Key Figures

Broker identifier: 11,876 Value-like figure: 647,857.18 Identifier-like number: 60,346,214 +5 more

8 metrics

Broker identifier 11,876 listed near broker line in excerpt

Value-like figure 647,857.18 numeric field present in excerpt

Identifier-like number 60,346,214 numeric field present in excerpt

Form date 05/22/2026 date shown near NYSE line

Sale date examples 12/15/2025; 12/16/2025 dates attached to listed lots of securities to be sold

Example lot size 2,109 shares restricted stock lot dated 12/15/2025

Example lot size 1,928 shares restricted stock lot dated 12/16/2025

Additional lot sizes 1,843; 2,615; 3,381 shares other listed restricted/performance-share lots dated 12/15/2025

Key Terms

Restricted Stock, Performance Shares, Form 144

3 terms

Restricted Stock financial

"Common | 12/15/2025 | Restricted Stock | Issuer"

Shares granted to an individual that carry limits on transfer or sale until certain conditions are met, such as staying with the company for a set time or hitting performance targets. Think of them as a locked gift that gradually opens; for investors they matter because they affect how many shares may enter the market later, signal management incentives and potential dilution, and reveal confidence in future company performance.

Performance Shares financial

"Common | 12/15/2025 | Performance Shares | Issuer"

Performance shares are a type of company stock given to executives or employees that only become theirs if the company meets specific goals, like hitting certain profits or growth targets. They motivate leaders to work toward the company’s success, because their additional shares depend on achieving these results.

Form 144 regulatory

"144: Filer Information"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does DLB's Form 144 filing indicate?

It indicates proposed sales of restricted and performance-based Common Stock, with specific lot dates of 12/15/2025 and 12/16/2025. The filing lists multiple share lots, including 2,109 and 1,928 shares as examples.

Who is the broker or placement agent named in the filing for DLB?

The filing names Morgan Stanley Smith Barney LLC Executive Financial Services at 1 New York Plaza. That broker-dealer is identified in the form information section as the intermediary associated with the proposed transactions.

What share amounts are listed in the DLB Form 144 excerpt?

The excerpt lists multiple lots of Common Stock to be sold, with sample lot sizes of 2,109, 1,928, 1,843, 2,615, and 3,381 shares, each tied to sale dates in December 2025.

When are the proposed sales in the DLB filing scheduled?

The proposed sale dates shown in the excerpt are primarily 12/15/2025 and one lot dated 12/16/2025. These dates are attached to the listed restricted and performance-share lots.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/22/2026 - 04:18 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001746636
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	DOLBY LABORATORIES, INC.
SEC File Number	001-32431
Address of Issuer	1275 Market Street San Francisco CALIFORNIA 94103-1410
Phone	(415) 558-0200
Name of Person for Whose Account the Securities are To Be Sold	TODD PENDLETON
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	11876	647857.18	60346214	05/22/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	12/15/2025	Restricted Stock	Issuer			2109	12/15/2025	Not Applicable
Common	12/16/2025	Restricted Stock	Issuer			1928	12/16/2025	Not Applicable
Common	12/15/2025	Restricted Stock	Issuer			1843	12/15/2025	Not Applicable
Common	12/15/2025	Restricted Stock	Issuer			2615	12/15/2025	Not Applicable
Common	12/15/2025	Performance Shares	Issuer			3381	12/15/2025	Not Applicable

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	05/22/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Todd Pendleton
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)